Tag: Glaucoma

No, bethanechol is not used to treat glaucoma; in fact, it can be contraindicated in certain forms of the condition. While it is a muscarinic agonist—a class of drugs that includes some glaucoma medications—bethanechol's effects primarily target the smooth muscle of the bladder and gastrointestinal tract, not the drainage pathways of the eye.

According to the Centers for Disease Control and Prevention, more than 13% of American adults take antidepressants, and some people wonder, 'Do SSRIs affect your eyes?' These widely prescribed medications can cause various eye-related side effects, from minor irritation to more serious complications in certain individuals.

According to a large 2023 study in *JAMA Ophthalmology*, users of calcium channel blockers (CCBs), including amlodipine, had an almost 40% higher odds of developing glaucoma compared to non-users. This surprising finding raises important questions about whether can amlodipine cause glaucoma and the nature of this potential connection.

Over 4 million adults in the US were prescribed amitriptyline in 2021, yet not everyone is a suitable candidate for this medication. Knowing who should avoid taking amitriptyline is crucial for preventing severe side effects, managing serious drug interactions, and ensuring patient safety.

While atropine has no absolute FDA-issued contraindications, it carries warnings for numerous conditions where its use requires caution [1.2.1]. Understanding who should not use atropine is crucial for patient safety, especially for individuals with pre-existing cardiovascular, obstructive, or neuromuscular disorders.

Globally, an estimated 13% of myopia control treatments involve atropine [1.3.2]. A primary concern for clinicians and patients is the question: **does topical atropine increase intraocular pressure (IOP)**, and what are the associated risks?

An estimated 3 million Americans have glaucoma, a leading cause of irreversible blindness. For these individuals, it is critically important to understand **what medication is contraindicated with glaucoma patients**, as certain drugs can dangerously elevate intraocular pressure.

While systemic atropine was found to increase intraocular pressure (IOP) by more than 6 mm Hg in 8% of normal adults, its effect, particularly in topical form, is highly nuanced [1.4.2]. The question 'Does atropine increase ocular pressure?' depends significantly on patient-specific factors.

Systemic atropine may increase intraocular pressure (IOP) by more than 6 mmHg in about 8% of normal adults [1.3.2]. This article explains the mechanisms behind this effect, detailing how does atropine affect eye pressure, particularly in individuals with different types of glaucoma.

Approximately 1.8 billion people worldwide are affected by presbyopia, a condition that pilocarpine is now used to treat. This fact underscores pilocarpine's role in vision correction, and firmly refutes the common misconception: Is pilocarpine a mydriatic drug? The answer is no; it is fundamentally a miotic agent.